Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis

Journal of Neuroimmunology

Volumn 97, Issue 1-2, 1999, Pages 110-118

  Rose, John W ^a,b   Welsh, Cynthia T ^a,b   Hill, Kenneth E ^a   Houtchens, Maria K ^a   Fujinami, Robert S ^b   Townsend, Jeannette J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Encephalomyelitis; ICAM 1; Monoclonal antibody

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DEMYELINATION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; BRAIN; CARDIOVIRUS INFECTIONS; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MYELIN BASIC PROTEINS; RECURRENCE; THEILOVIRUS;

EID: 0032914195     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00064-8     Document Type: Article

References (31)

1. Archelos J.J., Jung S., Maurer M., Schmeid M., Lassmann H., Tamatani T., Miyasaka M., Toyka K., Hartung H.-P. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intracellular adhesion molecule ICAM-1. Ann. Neurol. 34:1993;145-154.
2. Baron J., Madri J., Ruddle N., Hashim G., Janeway C. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
3. Calabresi P., Tranquill L., Dambrosia J., Stone L., Maloni H., Bash C., Frank J., McFarland H. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b. Ann. Neurol. 41:1997;669-674.
4. Cannella B., Cross A., Raine C.S. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J. Exp. Med. 172:1990;1521-1524.
5. Cannella B., Cross A., Raine C.S. Adhesion-related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing autoimmune encephalomyelitis. Lab. Invest. 65:1991;23-31.
6. Cannella B., Cross A., Raine C.S. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 46:1993;23-55.
7. Dopp J., Breneman S., Olschowka J. Expression of ICAM-1, VCAM-1, L-selectin and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J. Neuroimmunol. 54:1994;129-144.
8. Dore-Duffy P., Balabanov R., Rafols J., Swanborg R. Recovery phase of experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activation. J. Neurosci. Res. 44:1996;223-234.
9. Hynes R. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 9:1992;11-25.
10. Inoue A., Koh C., Yamazaki M., Ichikawa M., Isobe M., Ishsihara Y., Yagita H., Kim B. Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus induced demyelinating disease. Int. Immunol. 9:1997;1837-1847.
11. Isobe I., Yagita N., Dkumura K., Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science. 255:1992;1125-1127.
12. Jemison L., Williams S., Lublin F., Knobler R., Korngold R. Interferon-gamma-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis. J. Neuroimmunol. 47:1993;15-22.
13. Lindsey J., Steinman L. Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1 and MHC class II mRNA in the central nervous system during the development and resolution of experimental allergic encephalomyelitis. J. Neuroimmunol. 48:1993;227-234.
14. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:1988;443-449.
15. McCarron R., Wang L., Racke M., McFarlin D.E. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43:1993;23-30.
16. Moy V., Brian A. Signaling by lymphocyte function associated antigen 1 (LFA-1) in B cells: enhanced antigen presentation after stimulation through LFA-1. J. Exp. Med. 175:1992;1-7.
17. O'Neil J., Butter C., Baker D., Gschmeissner S., Kraal G., Butcher E., Turk J. Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology. 72:1991;520-525.
18. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 62:1990;3-6.
19. Petinelli C.B., McFarlin D.E. Adoptive transfer of allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2-T lymphocytes. J. Immunol. 127:1981;1420-1423.
20. Raine C.S. The Dale McFarlin Memorial Lecture: immunology of the multiple sclerosis lesion. Ann. Neurol. 36:1994;S61-S72. (Suppl.).
21. Raine C.S., Barnett L.B., Brown A., Behar T., McFarlin D.E. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:1979;150-157.
22. Raine C.S., Cannella B., Duijvestijn A., Cross A. Homing to central nervous system vasculature by antigen-specific lymphocytes. Lab. Invest. 63:1990;476-489.
23. Rossi C.P., Delacrouix M., Huittinga I., Mcallister A., van Roojen N., Classen E., Brahic M. Role of macrophages during Theiler's virus infection. J. Virol. 71:1997;336-3340.
24. Soilu-Hanninen M., Roytta M., Salonen R. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe invirus facilitated experimental allergic encephalomyelitis. J. Neuroimmunol. 72:1997;95-105.
25. Shrikant P., Chung I., Ballestas M., Benveniste E. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor alpha, interleukin-1 beta, and interferon-gamma in astrocytes. J. Neuroimmunol. 51:1994;209-220.
26. Steffen B., Butcher E., Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis. Am. J. Pathol. 145:1994;189-201.
27. Tsunoda I., Fujinami R. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55:1996;673-686.
28. Wilcox C., Ward A., Evans A., Baker D., Rothlein R., Turk J. Endothelial cell expression of the intercellular adhesion molecule (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 30:1990;43-51.
29. Willenborg D., Simmons R., Tamatani T., Miyasaka M. ICAM-1-dependent pathway is not critically involved in the inflammatory process of autoimmune encephalomyelitis or in cytokine induced inflammation of the central nervous system. J. Neuroimmunol. 45:1993;147-154.
30. Welsh C.T., Rose J.W., Hill K.E., Townsend J.J. Augmentation of adoptively transferred EAE by administration of monoclonal antibody specific for LFA-1 alpha. J. Neuroimmunol. 43:1993;161-167.
31. Yednock T., Cannon C., Fritz L., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βα1 integrin. Nature. 356:1992;63-66.